Spectral Computed Tomography With Photon-counting Detector
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- GE Healthcare
- Enrollment
- 30
- Locations
- 2
- Primary Endpoint
- Evaluate feasibility of the photon-counting CT in a clinical setting.
Study Overview
Brief Summary
The purpose of the study is to collect data to evaluate feasibility of the using photon-counting CT in a clinical setting.
Detailed Description
Data collected in this study includes an assessment of image quality parameters including spatial resolution, image contrast, and noise that will evaluate the product and how this photon-counting CT technology can be used to reduce the overall radiation dose in CT imaging, and enhance clinical applications for CT technology.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Device Feasibility
- Masking
- None
Eligibility Criteria
- Ages
- 50 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age >50 years
- •Normal renal function per standardized guidelines (GFR > 60 mL/min)
- •Previous CT examination at KS no more than 12 months prior to the study examination
- •Signed informed consent
Exclusion Criteria
- •Iodine contrast is contraindicated.
Arms & Interventions
Subject's Scanned with Investigational Device
Intervention: CT with a photon-counting detector (Device)
Outcomes
Primary Outcomes
Evaluate feasibility of the photon-counting CT in a clinical setting.
Time Frame: 1 year
The primary objective of this study is to collect and evaluate raw CT scan data collected using the photon-counting CT.
Secondary Outcomes
- Collect feedback on performance and images generated on the photon-counting CT.(1 year)
